Estrategias Combinadas en Inmunoterapia Traslacional
ITC
University of Freiburg
Friburgo de Brisgovia, AlemaniaPublikationen in Zusammenarbeit mit Forschern von University of Freiburg (2)
2019
-
Randomised phase II study of second-line olaratumab with mitoxantrone/prednisone versus mitoxantrone/prednisone alone in metastatic castration-resistant prostate cancer
European Journal of Cancer, Vol. 107, pp. 186-195
2012
-
CD8 T cell priming in the presence of IFN-α renders CTLs with improved responsiveness to homeostatic cytokines and recall antigens: important traits for adoptive T cell therapy
Journal of Immunology, Vol. 189, Núm. 7, pp. 3299-3310